| Write You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Finance > Investing > Take Money Home - Sell Half Positions on Winning Trades |
|
Write You - Take Money Home - Sell Half Positions on Winning Trades
Let’s say you’re day trading and employed the 10 a.m. rule to buy 1,000 shares of XYZ at 15 in the morning. Happily, by 3:30 p.m. the stock has zoomed to 20. As the closing bell approaches you face a According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product decision. You can sell all 1,000 shares of XYZ for a five dollar (33%) profit, which is a very good day’s work. Or you can stick with your position in anticipation of follow-through gains the next day ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in and additional profits on your 1,000 shares. Often a stock that has a big day will “gap up” at the open the following morning and add several more points in the first half hour or so. In most cases, lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. however, the wise course is to sell half the position (500 shares) heading into the close and put half of those profits into your account. Then you can hold the remaining 500 shares and look for an op here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ning gap the next morning. If that occurs, great! Your trade is even more profitable. However, if XYZ does not move higher the next morning or even declines, you can sell the remainder of your positio d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro . Your trade will still end nicely in the black because you pocketed profits the previous day. Note: We never let a stock fall far so much that it wipes out all our profit on the shares remaining in p ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc lay. The same goes for trades lasting several days, weeks or months. If your position has gained, say, 10-25% or more in a relatively short period, you can sell half, pocket those profits and let the easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi remainder run to hopefully greater gains. Many traders keep whittling down their position a little at a time and finally close it when they figure that they have maximized their profits. This approac nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically offers tremendous flexibility. For example, many high-flying stocks are prone to wide price swings. The savvy investor will hop aboard a stock in the early stages of an upswing and sell half position and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ s as it advances until finally selling out completely. Then the stock swings in the other direction, taking the price below his original buying price. When the stock bottoms out and begins another ups ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ing, he can go for another profitable ride. In our opinion, the winning investor plays defensively. He protects his capital by using a stop loss; he takes half profits when they are available; he tri ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a s to keep some shares in play to take advantage of the “wiggles” in the market. Our goal is to consistently “take money home”-, i.e., put profits into our account. For our money, that’s the best way dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod to win in this challenging game of investing. Breakouts through resistance are the most desirable of all trade opportunities. (This discussion will be the buy opportunity discussion of breakouts. (An cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin equal sell opportunity exists on breakdowns through support). A breakout is a penetration of resistance based on a pricing established over time with price reversals taken place at approximately the s tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen me price point in previous time periods. Sounds easy. Well it sure sounded easy when that guy in the $1000 seminar told me about it. I also read how easy it was in the $90 book on trading that said w t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ould make me a wealthy independent trader. Breakouts are wonderful if they continue. If they fail you can expect the pricing not to trend but to return to a range bound probably touching the lower pr ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust cing before it rises again. That price movement is probably beyond your stop loss and you will not be pleased. This occurs more often than you want to believe. Since so many other people see the brea y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products out they are as nervous about it as you are and you have a larger number of quick exits with the slightest wiggle. This is referred to as “buyers remorse” or a “bull trap”. What this really represents . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de is a serious hit against your P&L. Remember, breakouts are a product of an established range bound market. The continuation of the sideways market is the rule with a move away from support or resist elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip nce back into the trading range. That means a failed breakout is the rule. The breakout is the exception. Some traders believe the reverse is true. That can cost you a bundle of cash in trading losses tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Mailroom Supplies: Does Your Vendor Deliver Great Customer Service and Prices? Battling Adsense Graphics Restrictions with Better Content Affiliate Product Reviews - An Ultimate Selling Tactic
|